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ABSTRACT. Instrumental variables (IV) estimators are becoming increas-
ingly popular because they allow for estimating the average causal effect of an
exposure on an outcome in the presence of unmeasured confounders. Often, how-
ever, exposures are hard to measure and may carry errors which not only reflect
random noise, but also contain a systematic component. In this article, we study
the impact of such error-prone exposure measurements on IV estimators for the
average causal effect of exposure on outcome. In addition, we propose a class of
IV estimators for this effect under linear structural mean models, which correct
for possibly systematic measurement error in the presence of a baseline measure-
ment which is associated with the observed exposure and known not to modify
the causal effect of interest. Simulation studies and the analysis of a small blood
pressure reduction trial (n = 105) with treatment noncompliance confirm the ad-
equate performance of our estimators in finite samples. Our results demonstrate
that incorporating a limited amount of prior information about a weakly identified
parameter (e.g., the error mean) may yield substantial improvements.
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compliance; prior information; structural models; weak identifiability.
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1 INTRODUCTION
Instrumental variables (IV) methods have a long tradition in economics and
econometrics, where they are used in connection with structural equation models.
They have more recently entered the medical, epidemiological and biostatistical
literature (for reviews, see e.g. Greenland, 2000; Martens et al., 2006). These
methods succeed in estimating the average causal effect of an exposure on an
outcome, even in the presence of unmeasured confounding, by using a so-called
instrumental variable. This is a variable (i) which is associated with the exposure;
(ii) has no direct effect on the outcome; and (iii) does not share common causes with
the outcome (Herna´n and Robins, 2006). Instrumental variables arise naturally in
double-blind randomized controlled trials with treatment noncompliance because
randomization (i.e. the instrument) is associated with received treatment (i.e. the
exposure), does not affect the outcome other than through received treatment and
shares no common causes with the outcome by virtue of randomization. They
are hence frequently used to adjust for treatment noncompliance in randomized
experiments (see e.g. Goetghebeur and Vansteelandt, 2005 for a review) and for
the analysis of randomized encouragement designs (Ten Have et al., 2004). At the
same time, they are becoming increasingly popular in observational settings where
the conditions for an instrumental variable are nevertheless harder to justify. In
genetics, for instance, the random assortment of genes transferred from parents to
offspring - called ‘Mendelian randomization’ - resembles the use of randomization
2
http://biostats.bepress.com/harvardbiostat/paper70
in experiments and is therefore a natural instrumental variable for estimating the
effect of genetically affected exposures on a given trait (Sheehan and Didelez, 2005).
Casas et al. (2005) use this idea to assess the influence of plasma homocysteine
level on the risk of stroke with homozygosity at a specific allele as an instrumental
variable. In most observational studies no real or natural randomization is present,
in which case the availability of an instrumental variable must be assessed on
theoretical grounds. For instance, Leigh and Schembri (2004) use the observed
cigarette price per region as an instrumental variable to estimate the causal effect
of smoking on health, assuming that the price of cigarettes may only impact health
by mediating exposure to cigarette smoke.
With the increasing popularity of IV methods, there is a growing concern as to
how these methods would fare under violations of the study design, such as mea-
surement error in the exposure. The latter concern is particularly prevalent in the
context of noncompliance adjustment in clinical trials (Dunn, 1997; Goetghebeur
and Vansteelandt, 2005) because simple measurements of noncompliance (e.g. the
number of pills removed from the pill container) are notorious for overestimating
the amount of drug actually taken (Urquhart and De Klerk, 1998).
Random measurement error on the exposure is not alarming for IV estima-
tors in linear (structural mean) models (Robins, 1994; Goetghebeur and Lapp,
1997). Indeed, these estimators continue to be asymptotically unbiased with at
most a slight loss of efficiency, when random measurement error is ignored (Goet-
ghebeur and Vansteelandt, 2005). When measurement error is systematic, tests
of the causal null hypothesis of no effect remain valid, but effect estimates may
become biased. Because systematic error is often a real concern, especially in
the noncompliance problem that motivated this research, our goal in this arti-
cle is to investigate how IV estimators for the parameters in linear (structural
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mean) models may be adjusted for systematic measurement error. Goetghebeur
and Vansteelandt (2005) show how this can be done when the average size of the
error is known (conditional on covariate values). This allows for sensitivity analy-
ses to be performed, but leaves open the question of how to estimate the average
size of the measurement error and subsequently correct for it. Because of iden-
tifiability problems, the latter can only be realized when extraneous information
is available. One common source of information is an instrumental variable for
the measurement error (Buzas and Stefanski, 1996; Carroll et al., 2004, 2006). In
contrast to the previously defined instrumental variable which we used for con-
founder adjustment, this is a pre-exposure surrogate for the observed exposure (in
the sense that it is correlated with exposure) which is known not to modify the
exposure effect of interest. Our interest in such variables stems from the fact that
other common sources of information on the measurement error (e.g. repeated
measurements or validation samples) are typically not available in the problem
setting which motivated this research.
In the next section, using ideas from linear regression models with error in
the covariates (Carroll et al., 2006), we show how an instrumental variable for the
measurement error may help to correct IV estimators for systematic error under
linear structural mean models (Goetghebeur and Lapp, 1997; Robins, 1994). In
Section 2.3, we diagnose that the error-adjusted estimator behaves poorly in small
to moderate sample sizes as compared to the standard estimator which ignores
measurement error. We show in Section 3 that this is due to the average magnitude
of the error being weakly identified at causal effects close to zero. In Section 3, we
accommodate this by incorporating weak prior information in the form of bounds
on the magnitude of the average error. This leads to estimators for the causal
effect of observed exposure with good performance in finite samples, as confirmed
4
http://biostats.bepress.com/harvardbiostat/paper70
through the analysis of a small placebo-controlled hypertension trial in Section 4
and through simulation studies in Section 5. Our results offer more general insight
how to incorporate prior information about weakly identified nuisance parameters
in a frequentist analysis, in favour of precision for the target parameter.
2 ADJUSTING FORMEASUREMENT ERROR
2.1 Assumptions
We consider a study which is designed to collect data on a scalar exposure Zi,
a scalar outcome Yi and possibly on a set of baseline (i.e. pre-exposure) covariates
Xi for independent subjects i = 1, ..., n. The goal of the study is to assess the
average effect of exposure Zi on outcome Yi, which we define as a contrast, i.e.
E(Yi − Yi0|Zi,Xi), (1)
of observed outcomes Yi and potential exposure-free outcomes Yi0 (Rubin, 1978).
The latter indicates a reference response which would have been measured for
subject i if all conditions were the same as in the considered study, but no exposure
were received (e.g. if the assigned experimental treatment contained no active
dose). Furthermore, suppose that the exposure Zi is imprecisely measured so that
the observed exposure level Wi for subject i may differ from the actual exposure
level Zi, which is unobserved.
Due to the lack of observations on Yi0 and Zi, identification of the causal effect
(1) requires assumptions, which may realistically hold, but are partly untestable.
Assumption A1 (IV assumption): measurements are available for each subject
i on an instrumental variable Ri, which satisfies the following assumptions:
1. within strata of baseline covariates Xi, E(Yi0|Xi, Ri) = E(Yi0|Xi).
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2. exclusion restriction (Angrist, Imbens and Rubin, 1996): Ri has no direct
effect on the outcome (only an indirect effect via the exposure is possible).
In double-blind randomized trials of an asymptomatic disease, one expects these
assumptions to hold for randomization Ri since patients and physicians are un-
aware of the assigned treatment (Robins, 1994).
Assumption A2 (Consistency assumption): to link exposure-free outcomes to
the observed data, we assume that Yi = Yi0 for subjects with Zi = 0.
Assumption A3 (Model assumption): the causal effect (1) obeys the linear
structural mean model (Robins, 1994)
E(Yi − Yi0|Zi,Xi, Ri) = γ(Xi, Ri;ψ∗)Zi (2)
where γ(Xi, Ri;ψ) is a known function smooth in ψ, satisfying γ(Xi, Ri;0) =
0, and where ψ∗ is an unknown finite-dimensional parameter. For instance, in
placebo-controlled randomized experiments with Ri = 1 for subjects randomized
to the experimental arm and Ri = 0 for placebo control, we may choose
E(Yi − Yi0|Zi,Xi, Ri) = ψZiRi (3)
when subjects with Ri = 0 are not exposed to the experimental treatment. Here,
ψ expresses the expected change in outcome when those exposed to Zi = 1 would
have their exposure set to zero. When treatment effects are potentially modified
by pre-treatment covariates, one may add covariate-exposure interactions, as in
E(Yi − Yi0|Zi,Xi, Ri) = (ψ1 +ψ′2Xi)ZiRi.
Here, ψ2 defines the change in the average effect of unit exposure per unit increase
in Xi. Note that we will restrict our development to models (2) which postulate
the causal effect to be linear in the exposure. This is because linear structural
6
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mean models with nonlinear exposure effects suffer from identification problems,
even in the absence of measurement error (Vansteelandt and Goetghebeur, 2005).
Assumption A4 (Measurement error assumptions): Given the difficulty in ob-
taining information about measurement error characteristics, we will assume the
availability of an instrumental variable Ti ⊆ Xi for the measurement error for each
subject i. This is surrogate for the observed exposure (in the sense that is it is con-
ditionally associated with Wi, given (Si, Ri), where Si is such that Xi ≡ (Si,Ti)),
which is measured prior to exposure and is such that it does not modify the causal
effect of received exposure on the outcome, i.e. such that
E(Yi − Yi0|Zi,Xi, Ri) = E(Yi − Yi0|Zi,Si, Ri) (4)
We thus assume that γ(Xi, Ri;ψ) = γ(Si, Ri;ψ) in (2) does not involve Ti. For
instance, in clinical trials with a run-in period during which all patients receive
placebo tablets and compliance is monitored, one possible source of such instru-
mental variable would be compliance during the run-in period. This is because
run-in compliance is likely a good surrogate for the true exposure and because,
given the actual compliance during the active study period, run-in compliance
may not further relate to the treatment effect. Ten Have et al. (2007) make a
similar assumption for disentangling direct from indirect causal effects. Note that
Ti differs from and satisfies different assumptions than the instrumental variable
Ri, which satisfies assumption A1.
2.2 Inference
Our goal is to estimate the parameter ψ∗ indexing (2) under model A, which
is the model for the observed data (Yi,Wi, Ri,Xi) defined by assumptions A1-A4
7
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and with the conditional density
f(Ri|Xi) known. (5)
It follows from Proposition 1 below that the average measurement error δ(Xi, Ri) ≡
E(Wi − Zi|Xi, Ri) is all that must be known for identifying ψ∗.
Proposition 1. Model A is the same model for the observed data as the con-
ditional mean independence model B defined by (5) and
E [Yi − γ(Si, Ri;ψ∗) {Wi − δ(Xi, Ri)} |Xi, Ri]
= E [Yi − γ(Si, Ri;ψ∗) {Wi − δ(Xi, Ri)} |Xi] . (6)
For convenience, we will assume that δ(Xi, Ri) = δ
∗ is constant, although this
assumption will be straightforward to relax (see also the discussion). Our goal is
thus to estimate ψ∗ in model A when the average size δ∗ of the error is unknown.
Note that the restrictions which model A imposes on the error distribution are
very weak. First, it allows the error to be associated with both the true exposure Zi
and observed exposureWi. As such, the error model encompasses both the classical
and Berkson error model (Carroll et al., 2006). Second, by avoiding assumptions
about the conditional association between Wi and Yi, given Zi, it allows the error
to be differential (i.e. associated with outcome conditional on the exposure) (see
the proof of Proposition 1 for a more formal argument). This is important because,
for instance in a hypertension trial, patients may be more reluctant to ‘confess’
to noncompliance when their outcome (e.g. blood pressure) stayed below target
(e.g. remained high). Finally, model A makes no assumptions on the measurement
error distribution (other than restriction δ(Xi, Ri) = δ
∗, which is easy to relax).
This is useful because the error distribution can be very complex. For instance,
exposures can be very small in practice, in which case the negative errors become
constrained by the fact that negative exposures (i.e. doses) are never reported.
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By Proposition 1 and the fact that ψ∗ is the same functional of the observed
data under models A and B, inference for ψ∗ is the same under both models. It
follows that the set of all consistent and asymptotically normal (CAN) estimators
for ψ∗ is the same under models A and B, where the latter can be obtained as in
Robins (1994) by solving the mean independence estimating equations
n∑
i=1
d(Ri,Xi) [Yi − γ(Si, Ri;ψ)(Wi − δ)− q(Xi)] = 0 (7)
jointly for θ = (ψ′, δ)′, where d(Ri,Xi) = g(Ri,Xi) − E {g(Ri,Xi)|Xi} and
g(Ri,Xi) and q(Xi) are arbitrary index functions of the dimension of θ which
can be chosen in view of efficiency. In particular, the efficient score for ψ∗ under
model A is the same as the efficient score for ψ∗ under model B. When the condi-
tional variance of Yi − γ(Xi, Ri;ψ)(Wi − δ), given (Ri,Xi), is constant, the latter
is obtained by setting q(Xi) equal to
qopt(Xi) = E {Yi − γ(Si, Ri;ψ)(Wi − δ)|Xi, Ri}
and d(Ri,Xi) equal to dopt(Ri,Xi) = gopt(Ri,Xi)− E {gopt(Ri,Xi)|Xi} with
gopt(Ri,Xi) = E
{
∂γ(Si, Ri;ψ)(Wi − δ)
∂θ
|Xi, Ri
}
Theorem 1.
1. Under regularity conditions, the solution ψˆ(d, q) to (7) satisfies
√
n
(
ψˆ(d, q)−ψ∗
)
→N (0,Γ(d, q)) in distribution, where
Γ(d, q) = E−1
{
∂Ui(d, q;ψ
∗)
∂ψ
}
Var{Ui(d, q;ψ∗)}E−1′
{
∂Ui(d, q;ψ
∗)
∂ψ
}
(8)
with d(Ri,Xi) = (dψ(Ri,Xi), dδ(Ri,Xi)) and
Ui(d, q;ψ) =
[
dψ(Ri,Xi)− E {dψ(Ri,Xi)γ(Si, Ri;ψ)}
E {dδ(Ri,Xi)γ(Si, Ri;ψ)} dδ(Ri,Xi)
]
× [Yi − γ(Si, Ri;ψ)(Wi − δ)− q(Xi)]
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2. The average error δ∗ is not root-n estimable at ψ∗ = 0.
3. For arbitrary (d, q), Γ(dopt, qopt) ≤ Γ(d, q) where A ≤ B is defined as A−B
being semi-positive definite.
Part 1 of Theorem 1 confirms that the solution ψˆ(d, q) to (7) is a root-n CAN
estimator of ψ∗. This is even so at ψ∗ = 0 where δ∗ is not root-n estimable by
the fact that the expected derivative of the estimating function w.r.t. δ is zero at
ψ∗ = 0. Theorem 1 also shows how to calculate the efficient score Ui(dopt, qopt;ψ)
for ψ∗ in model A. For example, with binary Ri, Xi = Ti, γ(Si, Ri;ψ) = ψRi and
assuming homoscedasticity and constant randomization probabilities π = P (Ri =
1), the semi-parametric efficient score for ψ∗ is
(Ri−π) [E(Wi|Ri = 1,Xi)− E {E(Wi|Ri = 1,Xi)}] {Yi − ψ(Wi − δ)Ri − qopt(Xi)}
This score differs from the efficient score in the absence of biased measurement error
(i.e. assuming that δ∗ = 0) in that it carries the additional termE {E(Wi|Ri = 1,Xi)},
which corrects for estimation of the error mean. This term reduces the variance
of the estimating functions and, as such, encodes efficiency loss. Specifically, note
that the efficient score becomes 0 when the instrument T is uncorrelated with the
observed exposure, and hence that ψ∗ is not root-n estimable in that case. By the
same token, weak instruments for the measurement error (i.e. instruments which
are weakly correlated with observed exposure) yield unstable effect estimates.
2.3 Bias-variance Trade-off
The anticipated loss of efficiency of the error-adjusted estimator raises the
question whether the bias correction of the previous section is meaningful. To this
end, we investigate the bias-variance trade-off of using the error-adjusted instead
of the standard unadjusted estimator for the causal effect ψ∗. To obtain tractable
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expressions for the mean-squared error of both estimators, we assume that Z ∼
N(µz, σ
2
z), T |Z ∼ N(ν0 + ν1Z, σ2t|z), Y0|Z, T ∼ N(α0 + α1Z + α2T, σ20) and that
Y = Y0 + (ψ + ǫ)RZ with ǫ|Y0, Z, T ∼ N(0, σ2).
Under the working assumption of no systematic measurement error (i.e. fixing
δ∗ = 0 in equation (7) and not estimating it), the efficient score for ψ∗ is Uu(ψ) =
(0.5− R)E(W |T,R = 1){Y − ψRW − E(Y |R = 0, T )} in model A with Xi = Ti
under the above data-generating mechanism. It follows after some algebra that
the solution ψˆu to
∑n
i=1 Uui(ψ) = 0 has bias which can be approximated by
E−1
(
∂Uu(ψ)
∂ψ
)
E{Uu(ψ)} = ψδ(µz + δ)
σ2z − σ2z|t + (µz + δ)2
where σ2z|t = σ
2
zσ
2
t|z/(ν
2
1σ
2
z + σ
2
t|z) is the conditional variance of Z given T , and
asymptotic variance given by
1
n

4σ20 + 4α21σ2z|t + 2ψ2σ2u + ψ2δ2
σ2z − σ2z|t + (µz + δ)2
+
ψ2δ2(σ2z − σ2z|t){
σ2z − σ2z|t + (µz + δ)2
}2


Allowing for systematic measurement error, the efficient estimator ψˆc for ψ
∗ under
model A has no asymptotic bias and asymptotic variance which equals
1
n
σ20 + α
2
1σ
2
z|t + 0.5ψ
2σ2u
0.52(σ2z − σ2z|t)
Note that the bias and asymptotic variance of the estimators is inversely pro-
portional to the multiple correlation coefficient for the regression of Z on T , but
becomes infinite for the error-adjusted estimator when Z and T are uncorrelated.
Figure 1 shows the range of values δ for the average error under which the
standard estimator (which ignores measurement error) has smaller mean squared
error than the error-adjusted estimator, in function of the sample size and the
multiple correlation coefficient for the linear regression of Z on T . Specifically,
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the values of δ comprised between the solid lines indicate data-generating mecha-
nisms under which the standard estimator outperforms the error-adjusted estima-
tor in terms of mean squared error. The figure was constructed using the values
µz = 0.85, σ
2
z = 0.11, ν0 = 0.75, ν1 = 0.12, σ
2
t|z = 0.012, α0 = −4.4, α1 = 6.8, α2 =
−13.7, σ20 = 53.2, σ2u = 0, ψ = −7.5 and σ2 = 0 which are reflective of the hyper-
tension study that we will analyze in Section 4. The figure shows that at small
sample sizes (n = 105), correction for systematic measurement error may lead to
smaller mean squared error, but only when the systematic error component is sub-
stantial (i.e. of about the size of the average exposure µz) and, at the same time,
the instrument T is strongly correlated with Z. Further note that bias correction
using the error-adjusted estimator may be practical at moderate degrees of error
and moderate correlations between T and Z, but only at very large sample sizes.
Figure 1 about here
3 INCORPORATING PRIOR INFORMATION
The previous results demonstrate the poor performance of the error-adjusted
estimator, even in settings where the sample size is moderate and good (pre-
exposure) predictors of the exposure are available. In particular, tests of the causal
null hypothesis using this approach may be much less powerful than the standard
test of the causal null (i.e. that R and Y are independent), which is immune to
measurement error on the exposure. This is surprising, considering that the score
test of ψ∗ = 0 under model A does not involve δ∗ and hence that one need not
correct for measurement error when testing the causal null hypothesis. Curiously,
it follows that one can validly and efficiently test the causal null hypothesis with-
out needing to correct for measurement error, but that a score test of ψ∗ = ψ0
12
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with ψ0 arbitrarily close to (but different from) 0, would require correcting for
measurement error and hence could imply a serious and sudden loss of power.
The root cause of this apparent discontinuity is the fact that, as shown in
Part 2 of Theorem 1, δ∗ is not root-n estimable at ψ∗ = 0 so that estimation of δ∗
affects the distribution of the score test statistic, even though it gets multiplied by
ψ∗ = 0 in the test statistic (i.e. even at the causal null hypothesis). In particular,
it follows from the proof of Theorem 1 that
√
n
{
δˆ(d, q)− δ
}
ψ, with δˆ(d, q) the
solution for δ to (7), is bounded in probability with strictly positive variance for
each value of ψ, suggesting that δˆψ fluctuates around 0, even when ψ = 0, with
decreasing variance as the sample size increases.
Similar problems of inestimability at a local point in the parameter space
have been noted in other measurement error problems (Gustafson, 2005). More
general problems of inferring a parameter ψ∗ when a nuisance parameter δ∗ is
only present under the alternative (ψ∗ 6= 0) have received some attention, mainly
in the econometrics literature (Davies, 1977, 1987; Hansen, 1992; Andrews and
Ploberger, 1994). To the best of our knowledge, attention has only been given to
testing problems in which the test statistic involves a nuisance parameter which is
unidentified at the null. Some of these approaches assume that the nuisance pa-
rameter lies within a known open set and base inference on the supremum of a score
or likelihood ratio test statistic, taken over all values of the nuisance parameters
in the chosen set (Davies, 1977, 1987). Andrews and Ploberger (1994) postulate
a prior distribution for the nuisance parameter and base inference on the average
of a score or likelihood ratio test statistic over the chosen prior distribution. Our
problem is different (a) in that our main focus is on estimation rather than testing;
and (b) that a score test for the causal null hypothesis does not involve the nui-
sance parameter. Nonetheless, inspired by the work of Davies (1977, 1987) and by
13
Hosted by The Berkeley Electronic Press
sensitivity analyses for IV-estimators with measurement error (Goetghebeur and
Vansteelandt, 2005), we will consider estimation under the assumption that the
average error δ∗ lies within a known open set ∆. This strategy is motivated by
the fact that (a) subject-matter experts often have a rough idea about the degree
of mismeasurement (Gustafson, 2005); (b) this approach forces the estimate for δ∗
to have bounded variation around the truth, contrary to what happens under the
previous approach of Section 2.2; and (c) a little of prior information can often be
a very good thing (Gustafson, 2005). Furthermore, even when the set ∆ is chosen
excessively wide, this approach will improve the performance of error-adjusted es-
timators for ψ∗ dramatically by reducing variation in the estimates for the error
bias, especially when ψ∗ is close to zero (relative to the sample size).
3.1 Improved Error Adjustment
A first approach that we will consider under the assumption that δ∗ ∈ ∆ =
]∆l,∆u[ is to solve equations (7) with δ replaced by {I(λ < 0)∆l+I(λ > 0)∆u}λ/(1+
|λ|) and λ unknown. This guarantees estimates for δ∗ within the set ∆ and will
thus greatly improve the stability of estimators for the causal effect ψ∗. A draw-
back which will become apparent in the simulation study of Section 5, is that tests
of the causal null hypothesis may still loose substantial power under this approach
due to the fact that also λ is not root-n estimable at ψ∗ = 0. To accommodate
this, we will develop a second approach in this section, which we will recommend
for data analysis. Specifically, we propose to trade bias for precision by solving a
weighted average of the estimating functions for the standard SMM estimator and
for the error-adjusted estimator of Section 2.3. Here, we choose to weight the es-
timating functions for the standard estimator proportional to the probability that
the corresponding estimate for δ∗ falls outside the chosen set ∆. The philosophy
14
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behind this choice is that estimates for δ∗ will not likely fall within the set ∆ in
situations where little information on the error mean is available. Hence more
weight will be given to the standard unadjusted estimator in those cases.
For pedagogic purposes, we will explain our proposal for the case γ(Xi, Ri;ψ) =
ψRi. For notational convenience, we delete reference to the index functions (d, q)
in the estimators. For each value ψ in a chosen grid, we calculate an estimator δˆ(ψ)
for δ∗ which solves (7) for the given ψ with dδ(Ri,Ti,Xi) in place of d(Ri,Ti,Xi).
Next, we consider a weighted average of the estimating function Uψi(ψ, δ) for ψ
∗
(as defined in (7) with dψ(Ri,Ti,Xi) in place of d(Ri,Ti,Xi)), evaluated at the
profile estimator δ = δˆ(ψ) and at δ = 0, respectively:
1√
n
n∑
i=1
U˜i(ψ) ≡ 1√
n
n∑
i=1
Pˆ{δˆ(ψ) ∈ ∆}Uψi{ψ, δˆ(ψ)}+ Pˆ{δˆ(ψ) /∈ ∆}Uψi(ψ, 0)(9
In this expression, the weights involve the estimated probability Pˆ{δˆ(ψ) /∈ ∆} that
δˆ(ψ) falls outside the chosen interval ∆ =]∆l,∆u[. Using a similar development as
in the proof of Theorem 1, this probability can be approximated by
P{δˆ(ψ) /∈ ∆} = 1 + Φ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− Φ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)
(10)
with δ replaced by δˆ(ψ) and σ(ψ) replaced by a consistent estimator for the stan-
dard deviation of the scaled estimating function E−1 [dδ(R, T,X)R]Uiδ(ψ, δ) for
δ∗. We define the improved error-adjusted estimator ψ˜ for ψ∗ as the value of ψ
at which the score test (9) becomes zero. Curiously, this estimator assigns much
weight to the standard estimating equations (which do not adjust for measurement
error) when the error mean is estimated to be large. This is (a) because the phi-
losophy behind the estimator is that large values for the error mean are indicative
of imprecision; and (b) because the estimating functions are designed to equal the
unadjusted estimating functions at the causal null hypothesis (see further).
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Theorem 2. Under regularity conditions and for any fixed ψ, 1√
n
∑n
i=1 U˜i(ψ)→
N (0,Σ(ψ)) in distribution, where Σ(ψ) is the variance of
P{δˆ(ψ) ∈ ∆}Uiψ(ψ, δ) + P{δˆ(ψ) /∈ ∆}Uiψ(ψ, 0)−
[
P{δˆ(ψ) ∈ ∆}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
E {dψ(R, T )R}
E {dδ(R, T )R}Uiδ(ψ, δ)
Theorem 2 shows that for any fixed ψ, the score test (9) converges to a normal
mean zero distribution. This can be used to construct (1 − α)100% confidence
intervals for ψ∗ as the range of values ψ0 for ψ such that the two-sided score test
based on (9) does not reject the null hypothesis H0 : ψ
∗ = ψ0 at the α100%
significance level. To evaluate this score test, one may replace the variance of
the score test statistic by the sample variance with P{δˆ(ψ) ∈ ∆} replaced by
Pˆ{δˆ(ψ) ∈ ∆}, δ by δˆ(ψ) and σ(ψ) by σˆ(ψ). The resulting confidence intervals
have the desirable feature that, asymptotically, they exclude 0 if and only if the
standard test of the causal null hypothesis (i.e., that Y⊥⊥R) rejects. Indeed, at
the null hypothesis Pˆ{δˆ(0) /∈ ∆} p→ 1 and hence the score test statistic becomes
1√
n
n∑
i=1
Uψi(ψ, 0) =
1√
n
n∑
i=1
dψ(Ri,Ti,Xi){Yi − q(Ti,Xi)}+ op(1)
for an arbitrary mean zero function dψ(Ri,Ti,Xi) conditional on (Ti,Xi), which
is asymptotically equivalent to a score test of the causal null hypothesis under the
observed data model defined by restriction (5).
Unfortunately, the suggested confidence intervals are no uniform asymptotic
confidence intervals. The reason is that, at each sample size, there exists a ψ∗
depending on n which is sufficiently close to zero that the score test statistic (9) is
significantly biased as a result of bias in the estimating functions of the standard
unadjusted SMM estimator. Specifically, it follows from the proof of Theorem 2
that the improved error-adjusted estimator ψ˜ is asymptotically biased within root-
n shrinking neighbourhoods of zero (i.e. when ψ∗ = k/
√
n for some constant k)
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and may not converge to a normal distribution along such sequences. Curiously,
ψ˜ is asymptotically unbiased and normally distributed along faster converging
sequences (i.e. when ψ∗ = kn−a for some constant k and a > 1/2) and in particular
at ψ∗ = 0. The reason is that, although the probability that δˆ(ψ) ∈ ∆ now
converges to 0 and hence ψ˜ is asymptotically equivalent to the standard unadjusted
SMM estimator, ψ∗ is sufficiently close to zero to make any bias in the estimator
negligible. Likewise, ψ˜ is asymptotically unbiased and normally distributed along
slower converging sequences (i.e. when ψ∗ = kn−a for some constant k and 0 ≤
a < 1/2). The reason is that the probability of δˆ(ψ) ∈ ∆ now converges to 1
so that the improved error-adjusted estimator is asymptotically equivalent to the
error-adjusted estimator of Section 2.2, which is asymptotically unbiased.
The practical implication of the foregoing discussion is that the improved error-
adjusted estimator ψ˜ and confidence intervals have no guaranteed performance in
finite samples in the sense that, for each sample size, one can find a causal effect
ψ∗ which is close, but not too close to zero so that ψ˜ is significantly biased and
that confidence intervals for ψ∗ do not cover ψ∗ at the nominal level. This local
bias is the price we pay for estimators with smaller variability and limited loss of
power for testing the causal null hypothesis. Because this problem only appears
within 1 over root-n distances from zero and not within larger or shorter distances,
we expect adequate performance in many practical situations. However, in view
of this, we develop uniform asymptotic confidence intervals in the next section.
3.2 Uniform Asymptotic Confidence Intervals
Uniform asymptotic (1 − α)100% confidence intervals are expected to have
better finite-sample properties than the intervals of the previous section because
they guarantee the existence of a minimal sample size such that, at larger sample
17
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sizes, they cover ψ∗ with at least (1−α)100% chance regardless of the value of ψ∗.
Following ideas in Robins (2005), we construct such intervals by first constructing,
for each ψ, an asymptotic uniform (1 − ǫ)100% confidence interval C(ψ) for δ∗,
where the choice of ǫ < α will be discussed later. Because we assume the parameter
space for δ∗ to be ∆, a conservative asymptotic interval C(ψ) may be obtained as
{
δˆ(ψ)± zǫ/2 σˆ(ψ)|ψ|√n
}
∩∆
where σˆ(ψ) is a consistent estimator for σ(ψ). It follows from Theorem 5.1 in
Robins (2005) that an asymptotic uniform (1− α)100% confidence interval for ψ∗
may now be obtained as the set of ψ-values for which
inf
δ∈C(ψ)
|Var−1/2{Uψi(ψ, δ)} 1√
n
n∑
i=1
Uψi(ψ, δ)| < z(α−ǫ)/2
The optimal choice of ǫ that leads to confidence intervals of minimum length is
difficult to determine (Robins, 2005). In this article, we propose to choose ǫ in
function of ψ as 0.5α|ψ|/(1 + |ψ|). This choice guarantees that C(ψ) will equal ∆
for ψ∗ = 0 and equal a (1−α/2)100% confidence interval for δ∗ at causal effects ψ∗
far from 0. The philosophy behind this choice is that estimates for δ∗ will be highly
imprecise at causal effects close to zero and hence, given that the parameter space
for δ∗ is bounded, we expect no difference between 100% confidence intervals and
(1− α)100% confidence intervals for δ∗ at ψ∗ = 0. As such, we need not offer the
significance level for ψ∗ at small causal effects and will thus get narrower intervals
in return. Specifically, the proposed confidence intervals have the feature that they
involve no correction for measurement error at ψ∗ = 0, which is desirable because
there is no bias due to measurement error at ψ∗ = 0.
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4 DATA ANALYSIS
We analyze data from a placebo-controlled randomized hypertension trial
which enrolled some 300 hypertensive patients (Goetghebeur and Lapp, 1997).
After a run-in period of 4 weeks where all patients received placebo tablets, they
were randomized to 4 weeks of one of two active treatments (A or B) or placebo.
All treatments were prescribed at one tablet per day. Here, we analyze the sub-
set of 105 patients randomized to A or placebo, for whom treatment compliance
was electronically measured, ignoring 5 patients who had missing diastolic blood
pressure or pill counts.
An intent-to-treat analysis reveals an average difference in blood pressure re-
duction of 7.5 mmHg (95% CI 4.0; 11.0) without adjustment. This reveals the
effect of assignment to treatment A (instead of placebo) on expected diastolic
blood pressure reduction from baseline (i.e. the time of randomization). Primary
interest lies however in the effect of received treatment on average blood pressure
reduction. We will therefore fit model (3) with Yi the blood pressure reduction
over the active study period, Zi the average number of prescribed pills taken, and
Xi the age of patient i. Assuming that compliance measurements are free of sys-
tematic error, we estimate that the average blood pressure reduction would have
been 9.6 mmHg (95% CI 3.5; 11.8) smaller over the study period among those who
choose to take on average one pill per day, had they not taken the exposure.
Because this study was not designed to correct for measurement error, no nat-
ural instrumental variables for the measurement error have been recorded. Our
analysis is hence for illustrative purposes only and will use age as an instrumental
variable in the measurement error analysis. Age was chosen because effect mod-
ification through age is not anticipated (nor observed) in this study population,
which consists of middle aged hypertensive patients (5th, 95th percentiles: 41 and
19
Hosted by The Berkeley Electronic Press
69 years). A more adequate analysis would use placebo compliance during the
run-in period (which was not recorded here) as an instrumental variable. Using
the error-adjusted estimator of Section 2.2, we estimate a larger treatment effect
of 27.0 mmHg (95% CI -91.2; 145.2). To improve this imprecise result, we im-
pose the weak assumption that the average error is smaller than 0.25. We believe
this assumption to be reasonable, given that the observed percentage of assigned
dose taken (i.e. the observed exposure) is 0.85 (i.e., 85%) on average. Choosing
∆ = [−0.25, 0.25] thus allows for 30% of the observed average exposure to be due
to systematic error. Using the improved error-adjusted estimator for inference, we
estimate a slightly smaller effect of 9.0 mmHg (95% CI 4.4; 17.4) as compared
to the standard analysis. As predicted by the theory, the estimate is less precise
than the unadjusted estimator, but still significantly different from 0 at the 5%
significance level. The uniform asymptotic 95% confidence interval (2.7; 16.8) has
a more guaranteed performance in finite samples. To investigate the sensitivity
of our result to the choice of ∆, Figure 2 shows the improved error-adjusted es-
timate, along with uniform 95% confidence intervals in function of the maximum
error mean ∆u, with ∆ = [−∆u,∆u], and reveals reasonable stability. Comparison
with the sensitivity analysis results of Goetghebeur and Vansteelandt (2005) shows
that the error-adjustment described in this article reduces uncertainty.
Figure 2 about here
5 SIMULATION STUDY
To investigate the behaviour of the error-adjusted estimators in finite samples
with ψ∗ possibly close to zero, we conducted simulation experiments. Each ex-
periment was based on 5000 replications of random samples of size 105 (i.e. the
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sample size of the blood pressure study) or 1000, generated as follows. In each ex-
periment, the instrument T for the measurement error was normal with mean 0.83
and standard deviation 0.14 and R was independently generated from a Bernoulli
distribution with success probability 0.5. The true exposure Z and exposure-free
response were generated as Z = T +0.32ǫZ and Y0 = −4.4+6.8Z−7.3T +7.3ǫ0 for
independent standard normal variates ǫZ , ǫ0. Finally, we generated Y as Y0+ψRZ
and the observed exposure W as W = Z + U where U ∼ N(δ, 0.01).
Table 1 about here
Table 1 summarizes the results for estimation of ψ using i) the standard IV es-
timator which ignores systematic measurement error (STD); (ii) the error-adjusted
estimator of Section 3.1 (IV1); iii) the error-adjusted estimator of Section 3.3 which
guarantees estimates for δ to stay within ∆ = [∆l,∆u] with ∆u = −∆l equal to 0.5,
0.25 or 0.05, by defining δ = {I(λ < 0)∆l+ I(λ > 0)∆u}λ/(1+ |λ|) for unknown λ
(IV2); the improved error-adjusted estimator of Section 3.3 with the same choices
for ∆ (IV3). In addition, the table shows uniform asymptotic 95% confidence in-
tervals (UI) corresponding to these choices. The results for the different estimators
are as predicted by the theory. The error-adjusted estimator (IV1) is extremely
variable at small sample sizes, but performs adequately at larger sample sizes, even
at ψ = 0. Estimator (IV2) is less variable, although still substantially less precise
than the standard unadjusted estimator. Figures 3 and 4 show that estimator
(IV1) is normally distributed in moderate sample sizes, even at ψ = 0, but not
in small samples. It also shows that the improved error-adjusted estimator (IV3)
is much less variable than the error-adjusted estimator (IV1). While the former
follows a normal distribution in small samples, deviations from normality appear
in larger sample sizes as a result of convergence to a normal distribution not being
uniform in ψ. By the same token, the improved error-adjusted estimator is more
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biased than the error-adjusted estimator in larger samples, and even than the stan-
dard IV estimator in some scenarios. Informally, this happens because data sets
which carry evidence for causal effects close to zero, yield estimated probabilities
of δˆ(ψ) ∈ ∆ close to zero. The bias then arises because the small estimated causal
effects in such data sets will be more attracted towards the estimates obtained
from a standard structural mean analysis (which ignores measurement error) than
large estimated causal effects. Additional simulations (not displayed) have shown
that, as predicted by the theory, this bias and deviation from normality disappears
again in larger sample sizes. Furthermore, note that the confidence intervals for
the improved error-adjusted estimator retain their coverage despite these devia-
tions, although there is a tendency for the approach to be conservative. Finally, as
predicted by the theory, the uniform confidence intervals are conservative and also
wider on average than those obtained via the improved error-adjusted estimator.
The impact of narrower intervals ∆ = [−0.25, 0.25] was large at small sample
sizes, but moderate at large sample sizes. For instance, confidence intervals based
on the improved error-adjusted estimator had an average length of 8.42 (instead of
13.3) and coverage of 97.0% (instead of 97.7%) in small samples and 4.35 (instead
of 4.83) and 98.0% (instead of 97.8%), respectively, in large samples. The impact
of ∆ = [−0.05, 0.05] not including the error mean was to induce bias of the order
of magnitude of the standard unadjusted estimator. The 95% confidence intervals
based on the improved error-adjusted estimator and uniform 95% confidence in-
tervals then no longer cover at the nominal rate. Coverage of those intervals was
still better than the coverage of 95% confidence intervals based on the standard
unadjusted estimator, but at the expense of being wider.
Figures 3 and 4 about here
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6 CONCLUSIONS
We have proposed a general procedure to correct IV estimators for system-
atic error in the exposure when an instrumental variable for the measurement
error is available. This procedure complements the sensitivity analysis approach
of Goetghebeur and Vansteelandt (2005) and is especially attractive when the
instrumental variables assumption (A4) is likely to be met. This is the case in
placebo-controlled randomized trials with noncompliance where measurements on
run-in placebo compliance may very well meet assumption (A4). With concern for
compliance mismeasurement, recording run-in compliance may thus be favourable.
On theoretical grounds and on the basis of simulation experiments, we rec-
ommend the improved error-adjusted estimator of Section 3.1. This estimator
was designed so that adjustment for measurement error does not compromise the
power of tests of the causal null. This is attractive, knowing that standard tests of
the causal null hypothesis (i.e., that the instrument R is independent of outcome)
ignore exposure measurements and are thus valid in the presence of measurement
error. Because the proposed estimator does not converge uniformly to a normal
distribution, we recommend the uniform confidence intervals of Section 3.2.
For illustrative purposes, we have developed this work under structural mean
models which assume linear exposure effects that are not modified by pre-exposure
covariates. Extensions to linear structural mean models that allow for effect mod-
ification by baseline covariates are methodologically straightforward, but compu-
tationally more demanding. Finally, we believe our results to be more broadly
useful as they suggest, in line with Gustafson (2005), that incorporating a little
prior information on a weakly identified nuisance parameter may yield substantial
efficiency improvements for the target parameter. In addition, they indicate how
such prior information may be adopted.
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APPENDIX: PROOFS
Proposition 1. Model A implies model B because
E (Yi0|Xi, Ri) = E {Yi − γ(Si, Ri;ψ∗)Zi|Xi, Ri}
= E [Yi − γ(Si, Ri;ψ∗) {Wi − δ(Xi, Ri)} |Xi, Ri]
by (A3) and because E (Yi0|Xi, Ri) = E (Yi0|Xi) by (A1). Note that this does not
require assumptions about the conditional association between Yi and Wi, given
Zi, suggesting that this continues to hold when measurement error is differential.
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http://biostats.bepress.com/harvardbiostat/paper70
To show that (6) is the only restriction (other than (5)) imposed on the ob-
served data law, we proceed as in Robins and Rotnitzky (2004) by exhibiting
for any observed data law satisfying (5) and (6), a joint law of the full data
(Y, {Yrz,∀r, z}, Z,W,R,X, T ) satisfying the restrictions of model A, where Yrz is
the potential outcome that would have been observed for given subject following
exposure to (R,Z) = (r, z), all other experimental conditions being the same as
in the considered study. Given (R = r, Z = z,W = w,X = x, T = t, Y = y), we
define Yrz = y to satisfy (A2). We set f(Z|R = r,W = w,X = x, T = t, Y = y)
equal to an arbitrary density with conditional mean w − δ. We define f(Yr0|R =
r, Z = z,W = w,X = x, T = t, Y = y) to be an arbitrary density with conditional
mean y − γ(x, r;ψ∗)z. In addition, given (Z = z,W = w,X = x, T = t, Y = y),
we set Yr0 = Yr′0 ≡ Y0 for each (r, r′) to satisfy (A1). By (6), the conditional dis-
tribution of Y0 then also satisfies E(Y0|X = x, T = t, R) = E(Y0|X = x, T = t) for
each (x, t). Remaining features of the full data density can be chosen arbitrarily.
Theorem 1. Let for simplicity of exposition, but without loss of generality,
γ(Xi, Ri;ψ) = ψRi. Define Uiδ = dδ(Ri,Ti,Xi) [Yi
−ψ(Wi − δ)Ri − q(Ti,Xi)] and Uiψ = dψ(Ri,Ti,Xi) [Yi − ψ(Wi − δ)Ri − q(Ti,Xi)]
the estimating functions for δ∗ and ψ∗, respectively. Then standard asymptotic
theory for M-estimators (van der Vaart, 1998) and Taylor expansions show that
0 =
1√
n
n∑
i=1
Uiδ + E
(
∂Uiδ
∂ψ
)√
n(ψˆ − ψ∗) + E
(
∂Uiδ
∂δ
)√
n(δˆ − δ∗)
+
1
2
E
(
∂2Uiδ
∂ψ∂δ
)√
n(ψˆ − ψ∗)(δˆ − δ∗) + op(1) (11)
from which
√
n(δˆ − δ∗) ψˆ + ψ
∗
2
= op(1)− E−1 {dδ(Ri,Ti,Xi)Ri}
×
[
1√
n
n∑
i=1
Uiδ − E {dδ(Ri,Ti,Xi)(Wi − δ∗)Ri}
√
n(ψˆ − ψ∗)
]
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Plugging this into a first order Taylor expansion of Uiψ, shows that
√
n(ψˆ − ψ∗)
equals
−
[
E {dψ(Ri,Ti,Xi)(Wi − δ∗)Ri} − E {dψ(Ri,Ti,Xi)Ri}
E {dδ(Ri,Ti,Xi)Ri}E {dδ(Ri,Ti,Xi)(Wi − δ)Ri}
]−1
×
[
1√
n
n∑
i=1
Uiψ − E {dψ(Ri,Ti,Xi)Ri}
E {dδ(Ri,Ti,Xi)Ri}Uiδ
]
+ op(1)
It follows that
√
n(ψˆ − ψ) = Op(1) and that Part 1 of Theorem 1 holds.
Note that the last 2 terms in (11) can be replaced byE {dδ(Ri,Ti,Xi)Ri}
{
ψ +Op(n
−1/2)
}
×√n(δˆ − δ), from which √n(δˆ − δ)ψ = √n(δˆ − δ)(ψˆ + ψ∗) {1/2 + op(1)} equals
−
[
E {dδ(Ri,Ti,Xi)Ri} − E {dδ(Ri,Ti,Xi)(Wi − δ
∗)Ri}
E {dψ(Ri,Ti,Xi)(Wi − δ∗)Ri}E {dψ(Ri,Ti,Xi)Ri}
]−1
×
[
1√
n
n∑
i=1
Uiδ − E {dδ(Ri,Ti,Xi)(Wi − δ
∗)Ri}
E {dψ(Ri,Ti,Xi)(Wi − δ∗)Ri}Uiψ
]
+ op(1)
The latter expression is bounded in probability (under standard regularity con-
ditions). It follows that, as ψ∗ goes to zero with increasing sample size, δˆ does
not converge to δ∗ at root-n rate and hence is not uniformly root-n consistent. In
particular, there is no root-n consistent estimator of δ∗ under model A at ψ∗ = 0.
Part 2 of Theorem 1 is immediate from Robins (1994).
Proof of Theorem 2. Let for simplicity of exposition, but without loss of
generality, γ(Xi, Ri;ψ) = ψRi. Then standard asymptotic theory for M-estimators
(van der Vaart, 1998) and Taylor expansions of the estimating functions (9) for ψ∗
w.r.t. δˆ(ψ) shows that (9) equals
1√
n
n∑
i=1
P{δˆ(ψ) ∈ ∆}Uiψ(ψ, δ) + P{δˆ(ψ) /∈ ∆}Uiψ(ψ, 0) + op(1)−
[
P{δˆ(ψ) ∈ ∆}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
E {dψ(R, T )R}
E {dδ(R, T )R}Uiδ(ψ, δ) (12)
That the remainder term converges to zero in probability for any fixed ψ can be
seen because, for some δ˜ on the open line segment between δˆ(ψ) and δ∗ (under stan-
dard regularity conditions which include uniform convergence of n−1
∑n
i=1 Uiψ(ψ, δ)
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w.r.t. δ), the remainder term equals[
Pδ=δ˜{δˆ(ψ) ∈ ∆}E
{
∂2
∂δ2
Uiψ(ψ, δ˜)
}
+ 2
∂
∂δ
Pδ=δ˜{δˆ(ψ) ∈ ∆}E
{
∂
∂δ
Uiψ(ψ, δ˜)
}
+
∂2
∂δ2
Pδ=δ˜{δˆ(ψ) ∈ ∆}E
{
Ui0(ψ)− Uiψ(ψ, δ˜)
}] √n
2
{δˆ(ψ)− δ∗}2 + op(1)
Here, the first term is zero. Because E
{
∂Uiψ(ψ, δ˜)/∂δ
}
= Op(1)ψ under standard
regularity conditions and
√
n{δˆ(ψ)− δ∗}2 = Op(1)n−1/2ψ−2, the second term is
Op(1)
{
ϕ
(
∆l − δ˜
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ˜
σ(ψ)/(
√
n|ψ|)
)}
1
σ(ψ)
= op(1)
for any fixed ψ. Because E
{
Ui0(ψ)− Uiψ(ψ, δ˜)
}
= Op(1)δψ, the third term is
{
ϕ
(
∆l − δ˜
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ˜
σ(ψ)/(
√
n|ψ|)
)}
n|ψ|ψδ˜
σ(ψ)3
(∆l −∆u) = op(1)
for any fixed ψ because xaϕ(x)→ 0 as x→∞ for arbitrary a > 0.
Because the estimating functions in (12) have mean and variance depending
on the sample size, we use the triangular array Central Limit Theorem (Serfling,
1980, p.31) to derive the asymptotic distribution of (9) for fixed ψ. Application
of this Theorem shows that for arbitrary fixed ψ, the estimating functions in (9)
are asymptotically normally distributed under the weak regularity condition that
the standard deviation of the estimating functions U˜i(ψ), as defined by (12), is
bounded (i.e. O(1)) and that asymptotically E‖U˜i(ψ)− E{U˜i(ψ)}‖k = o(nk/2−1).
Because for any fixed ψ∗ 6= 0 and δ∗ ∈ ∆ =]∆l,∆u[, P{δˆ(ψ∗) ∈ ∆} converges
to 1, it follows under these conditions that n−1/2
∑n
i=1 U˜i(ψ
∗) will be asymptoti-
cally normally distributed with mean zero and finite variance, which is given by
the variance of (12). Within faster than root-n shrinking neighbourhoods of zero
(i.e. if ψ∗ = kn−a for some constant k and a > 1/2), the remainder term in the
Taylor series expansion is still op(1). Further, P{δˆ(ψ∗) ∈ ∆} converges to 0 and
U0(ψ
∗) has mean converging to zero at 1 over na-rate. It then again follows that
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n−1/2
∑n
i=1 U˜i(ψ
∗) is asymptotically normally distributed with mean zero and finite
variance. Finally, within 1 over root-n shrinking neighbourhoods of zero (i.e. if
ψ∗ = kn−1/2 for some constant k), the remainder term in the Taylor series expan-
sion is bounded in probability, but not op(1). The significant contribution of the
squared term
√
n{δˆ(ψ∗)−δ∗}2 implies that n−1/2∑ni=1 U˜i(ψ∗) may not converge to
a normal distribution, nor to a mean zero distribution along such sequences. The
implications of this will be discussed in the next paragraph.
To gain insight into the asymptotic distribution of ψ˜ (rather than its estimating
function), we make a further Taylor series expansion of the estimating functions,
evaluated at ψ˜. This shows that for any fixed ψ
0 =
1√
n
n∑
i=1
P{δˆ(ψ) ∈ ∆}Uiψ(ψ, δ) + P{δˆ(ψ) /∈ ∆}Uiψ(ψ, 0) + op(1)−
[
P{δˆ(ψ) ∈ ∆}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
E {dψ(R, T )R}
E {dδ(R, T )R}Uiδ(ψ, δ)
+
(
P{δˆ(ψ) ∈ ∆}E
{
∂
∂ψ
Uiψ(ψ, δ)
}
+ P{δˆ(ψ) /∈ ∆}E
{
∂
∂ψ
Uiψ(ψ, 0)
}
+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ(∆l −∆u)
σ(ψ)
E {dψ(R, T )R}
−
[
P{δˆ(ψ) ∈ ∆}+
{
ϕ
(
∆l − δ
σ(ψ)/(
√
n|ψ|)
)
− ϕ
(
∆u − δ
σ(ψ)/(
√
n|ψ|)
)} √
n|ψ|δ
σ(ψ)
]
E {dψ(R, T )R}
E {dδ(R, T )R}
×E {dδ(R, T )R(W − δ)})
√
n(ψ˜ − ψ) (13)
That the remainder term converges to zero in probability for any fixed ψ can be
seen using a similar derivation as before. We conclude that, up to an op(1) term
and for fixed ψ,
√
n(ψ˜ − ψ) is a linear transformation of n−1/2∑ni=1 U˜i(ψ) and
thus shares its asymptotic properties. Specifically, within faster and slower than 1
over root-n shrinking neighbourhoods of zero (and in particular at arbitrary fixed
ψ),
√
n(ψ˜ − ψ) is asymptotically normally distributed with mean zero and finite
variance under weak regularity conditions. Within 1 over root-n neighbourhoods
of zero,
√
n(ψ˜ − ψ) may be asymptotically biased and not normally distributed.
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Figure 1: Curves indicating the tuples (R2, δ) where the standard SMM estimator
and the error-adjusted instrumental variable estimator have the same mean squared
error, for different sample sizes n = 105, 1000 and 5000 and with R2 equalling the
multiple correlation coefficient for the regression of Z on T . Left: for R2 from 0
to 1; Right: for R2 from 0.25 to 1. 31
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Figure 2: Improved error-adjusted estimate, along with uniform 95% confidence
intervals in function of the maximum error mean ∆u, with ∆ = [−∆u,∆u].
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Figure 3: QQ-plots for n = 105. Row 1: error-adjusted estimator IV1; Row 2:
improved error-adjusted estimator IV3; Column 1: ψ = −7.5, δ = 0.15; Column 2:
ψ = −7.5, δ = 0; Column 1: ψ = 0, δ = 0.
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Figure 4: QQ-plots for n = 1000. Row 1: error-adjusted estimator IV1; Row 2:
improved error-adjusted estimator IV3; Column 1: ψ = −7.5, δ = 0.15; Column 2:
ψ = −7.5, δ = 0; Column 1: ψ = 0, δ = 0.
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Table 1: Bias of the different estimators and coverage and average length of corresponding 95% confidence intervals.
∆ n ψ δ Bias Coverage Average length CI
STD IV1 IV2 IV3 STD IV1 IV2 IV3 UI STD IV1 IV2 IV3 UI
0.5 105 -7.5 0.15 1.11 -3.77 -2.65 0.68 86.8 96.5 99.8 97.7 99.8 5.87 3039 56.2 13.3 18.8
0.5 105 -7.5 0 -0.020 -3.77 -2.31 -0.046 93.7 96.5 99.9 98.7 100 6.96 3039 55.7 10.8 29.2
0.5 105 0 0 -0.015 -3.63 -0.019 -0.0096 93.5 96.5 100 94.1 96.2 6.94 3027 63.8 8.88 21.1
0.5 1000 -7.5 0.15 1.13 -0.15 -0.28 0.81 36.4 95.1 99.9 97.8 100 1.90 14.0 14.0 4.83 11.4
0.5 1000 -7.5 0 -0.0048 -0.15 -0.52 -0.62 95.0 95.1 98.1 95.1 100 2.25 14.0 14.0 12.4 16.7
0.5 1000 0 0 -0.0042 -0.14 0.0032 -0.0036 94.9 95.2 100 95.0 96.2 2.24 14.0 13.9 2.78 5.86
0.25 105 -7.5 0.15 1.11 -3.77 0.59 1.06 86.8 96.5 100 97.0 99.5 5.87 3039 56.4 8.42 10.9
0.25 105 -7.5 0 -0.020 -3.77 -0.63 -0.062 93.7 96.5 100 98.8 99.9 6.96 3039 56.8 10.7 14.2
0.25 105 0 0 -0.015 -3.63 -0.013 -0.010 93.5 96.5 100 94.2 94.9 6.94 3027 67.8 8.88 11.6
0.25 1000 -7.5 0.15 1.13 -0.15 0.42 0.78 36.4 95.1 100 98.0 99.9 1.90 14.0 13.9 4.35 5.69
0.25 1000 -7.5 0 -0.0048 -0.15 -0.37 -0.19 95.0 95.1 100 95.8 99.6 2.25 14.0 14.0 5.83 7.61
0.25 1000 0 0 -0.0042 -0.14 -0.0012 -0.0036 94.9 95.2 100 95.0 95.5 2.24 14.0 13.9 2.78 3.43
0.05 105 -7.5 0.15 1.11 -3.77 1.07 1.11 86.8 96.5 100 91.3 94.8 5.87 3039 63.9 6.54 7.47
0.05 105 -7.5 0 -0.020 -3.77 -0.052 -0.015 93.7 96.5 100 96.3 98.2 6.96 3039 64.4 7.87 9.07
0.05 105 0 0 -0.015 -3.63 -0.014 -0.016 93.5 96.5 100 94.1 94.3 6.94 3027 67.9 7.53 8.51
0.05 1000 -7.5 0.15 1.13 -0.15 1.02 1.11 36.4 95.1 100 54.2 74.9 1.90 14.0 13.9 2.32 2.78
0.05 1000 -7.5 0 -0.0048 -0.15 -0.031 -0.0063 95.0 95.1 100 98.3 99.7 2.25 14.0 13.9 2.83 3.43
0.05 1000 0 0 -0.0042 -0.14 -0.0037 -0.0042 94.9 95.2 100 95.0 95.1 2.24 14.0 13.9 2.36 2.55
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